Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Nonfebrile seizures after mumps, measles, rubella, and varicella-zoster virus combination vaccination with detection of measles virus RNA in serum, throat, and urine.

Eckerle I, Keller-Stanislawski B, Santibanez S, Buderus S, Hillmann M, Drosten C, Eis-Hübinger AM.

Clin Vaccine Immunol. 2013 Jul;20(7):1094-6. doi: 10.1128/CVI.00084-13. Epub 2013 May 1.

2.

Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.

3.

Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.

Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, Prieler A, Maurer H, Bisanz H, Tornieporth N, Descamps D, Willems P.

Pediatr Infect Dis J. 2006 Jan;25(1):12-8.

PMID:
16395096
4.

Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.

Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, Baxter R, Hambidge S, Nordin J, Naleway A, Belongia EA, Lieu T, Baggs J, Weintraub E; Vaccine Safety Datalink.

Pediatrics. 2010 Jul;126(1):e1-8. doi: 10.1542/peds.2010-0665. Epub 2010 Jun 29.

PMID:
20587679
5.

Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.

Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P.

Pediatr Infect Dis J. 2008 Aug;27(8):724-30. doi: 10.1097/INF.0b013e318170bb22. Erratum in: Pediatr Infect Dis J. 2013 Apr;32(4):e163.

PMID:
18600190
6.

Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.

Leung JH, Hirai HW, Tsoi KK.

Expert Rev Vaccines. 2015;14(8):1149-57. doi: 10.1586/14760584.2015.1057572. Epub 2015 Jun 16.

PMID:
26081133
7.

Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.

Knuf M, Zepp F, Helm K, Maurer H, Prieler A, Kieninger-Baum D, Douha M, Willems P.

Eur J Pediatr. 2012 Mar;171(3):463-70. doi: 10.1007/s00431-011-1569-4. Epub 2011 Sep 21.

PMID:
21935584
8.

Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine.

Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Morb Mortal Wkly Rep. 2008 Mar 14;57(10):258-60.

9.

The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.

Durando P, Esposito S, Bona G, Cuccia M, Desole MG, Ferrera G, Gabutti G, Pellegrino A, Salvini F, Henry O, Povey M, Marchetti F.

Vaccine. 2016 Aug 5;34(36):4278-84. doi: 10.1016/j.vaccine.2016.07.009. Epub 2016 Jul 14.

10.
11.

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.

Nolan T, McIntyre P, Roberton D, Descamps D.

Vaccine. 2002 Dec 13;21(3-4):281-9.

PMID:
12450703
12.
13.

Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.

Shinefield H, Black S, Williams WR, Marchant C, Reisinger K, Stewart T, Meissner HC, Guerrero J, Klopfer SO, Xu J, Schödel F, Kuter BJ; Dose Selection Study Group for Proquad.

Pediatr Infect Dis J. 2005 Aug;24(8):670-5. Erratum in: Pediatr Infect Dis J. 2005 Nov;24(11):983.

PMID:
16094218
14.

Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: what do primary care physicians think?

O'Leary ST, Suh CA, Marin M; Vaccine Policy Collaborative Initiative.

Vaccine. 2012 Nov 6;30(48):6731-3. doi: 10.1016/j.vaccine.2012.08.075. Epub 2012 Sep 10.

PMID:
22975026
15.

Post-vaccine measles in a child with concomitant influenza, Sicily, Italy, March 2015.

Tramuto F, Dones P, D Angelo C, Casuccio N, Vitale F.

Euro Surveill. 2015 May 21;20(20). pii: 21134.

16.
17.

Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.

Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM; LAIV Study Group.

Pediatrics. 2008 Mar;121(3):508-16. doi: 10.1542/peds.2007-1064.

PMID:
18310199
18.

A combination vaccine against measles, mumps, rubella and varicella.

Knuf M, Faber J, Barth I, Habermehl P.

Drugs Today (Barc). 2008 Apr;44(4):279-92. Review.

PMID:
18536786
19.

The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.

Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ; Consistency Lot Study Group for ProQuad.

Pediatr Infect Dis J. 2006 Jul;25(7):615-22.

PMID:
16804432
20.

[Combined or coadministred Measles, Mumps, Rubella and Varicella Vaccines? That is the question!].

Laudati F, Zaratti L, Franco E.

Ig Sanita Pubbl. 2012 Mar-Apr;68(2):313-21. Italian.

PMID:
23064094

Supplemental Content

Support Center